Down regulation by iron of prostaglandin E2 production by human synovial fibroblasts.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 10070275.
- Also identified by PMC identifier 1752513.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To examine the effect of iron on the prostaglandin (PG) E2 production by human synovial fibroblasts in vitro. Human synovial fibroblasts were isolated from synovial tissue of rheumatoid arthritis (RA) and osteoarthritis (OA) patients and cultured in medium. Synovial fibroblasts were stimulated by human recombinant interleukin (IL) 1 beta (0.1-10 ng/ml) with or without ferric citrate (Fe-citrate, 0.01-1 mM). The amount of PGE2 in the culture medium was measured by an enzyme linked immunosorbent assay. The production of PGE2 by the synovial fibroblasts was increased by stimulation with IL1 beta at all concentrations tested. Fe-citrate but not sodium citrate (Na-citrate) down regulated the production of PGE2 by the synovial fibroblasts, both with and without stimulation by IL1 beta. Fe-citrate inhibited the spontaneous PGE2 production by the cells in a dose dependent manner, and a maximum inhibition by Fe-citrate was observed at the concentration of 0.1 mM with IL1 beta stimulation. The down regulation by iron was reversed by the co-addition of desferrioxamine (100 micrograms/ml), an iron chelator. Iron down regulates the PGE2 production by synovial fibroblasts in vitro.
Medical subject headings
- Arthritis, Rheumatoid
- Dinoprostone
- Ferric Compounds
- Osteoarthritis, Knee
- Synovial Membrane